PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings
04 Février 2021 - 7:00PM
PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its
fourth quarter and full year 2020 results after the market closes
on Thursday, February 25, 2021. The Company will also host a
conference call on Friday, February 26, 2021 at 9:00 a.m. (ET) to
discuss the results with members of the investment community.
To participate via telephone, investors and analysts should dial
(877) 930-8062 within the United States or (253) 336-7647 outside
the United States approximately 10 minutes prior to the call start
time. The conference ID for the call is 1139426. An audio replay of
the call will be available for one week following the call and can
be accessed by dialing (855) 859-2056 within the United States or
(404) 537-3406 outside the United States. The replay ID is
1139426.
A live audio broadcast will be available on the investor
relations section of the PRA Health Sciences website. Following the
teleconference, an audio playback of the call will be available at
the same website.
ABOUT PRA HEALTH SCIENCES
PRA Health Sciences is one of the world’s leading global
contract research organizations by revenue, providing outsourced
clinical development and data solution services to the
biotechnology and pharmaceutical industries. PRA’s global clinical
development platform includes more than 75 offices across North
America, Europe, Asia, Latin America, Africa, Australia and the
Middle East and more than 18,100 employees worldwide. Since 2000,
PRA has participated in approximately 4,000 clinical trials
worldwide. In addition, PRA has participated in the pivotal or
supportive trials that led to U.S. Food and Drug Administration or
international regulatory approval of more than 95 drugs. To learn
more about PRA, please visit www.prahs.com.
INVESTOR INQUIRIES: InvestorRelations@prahs.com
PRA Health Sciences (NASDAQ:PRAH)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
PRA Health Sciences (NASDAQ:PRAH)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024
Real-Time news about PRA Health Sciences Inc (NASDAQ): 0 recent articles
Plus d'articles sur